Middle East & Africa Self-injections Market to 2032
Overview
The Middle East & Africa Self-injections Market is expected to reach a 5.86 USD Billion by 2032 and is projected to grow at a CAGR of 9.70% from 2025 to 2032.
Revenue, 2024 (USD Billion)
3.06
Forecast, 2032 (USD Billion)
5.86
CAGR, 2024 - 2032
9.70%
Report Coverage
Middle East & Africa
Middle East & Africa Self-injections Market 2018-2032 USD Billion
Middle East & Africa Self-injections Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 3.06 USD Billion
- Projected Market Size (2032): 5.86 USD Billion
- CAGR (2025-2032): 9.70%
Key Findings of Middle East & Africa Self-injections Market
- The Middle East & Africa Self-injections Market was valued at 3.06 USD Billion in 2024.
- The Middle East & Africa Self-injections Market is likely to grow at a CAGR of 9.70% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Subcutaneous in Route of Administration Segment accounted for the largest share of the market with a revenue of 2.68 USD Billion
- The fastest growing segment Autoimmune Diseases in Application Segment grew Fastest with a CAGR of 10.39% during the forecast period from 2024 to 2032.
Middle East & Africa Self-injections Market Scope
Middle East & Africa Self-injections Market Segmentation & Scope
Gender
- Female
- Male
Age Group
- Pediatric
- Geriatric
- Adult
Application
- Others
- Hormonal Disorders
- Oncology
- Emergency Drugs
- Pain Management
- Autoimmune Diseases
Distribution Channel
- Others
- Online Pharmacy
- Hospital Pharmacy
- Direct Tender
Product Type
- Self-Injection Formulation
- Self-Injection Devices
Route of Administration
- Others
- Intra muscular
- Subcutaneous
Dosage Form
- Multi-Dose
- Single Dose
Middle East & Africa Self-injections Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2023 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 3.06 USD Billion |
| Market Value in 2032 | 5.86 USD Billion |
| CAGR (2025-2032) | 9.70% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Gender,Age Group,Application,Distribution Channel,Product Type,Route of Administration,Dosage Form |
Regional Insights:
-
Leading Market (2024-2032): Middle East & Africa, leading in terms of revenue 3.06 USD Billion in 2024
- Key Country: South Africa, leading in terms of revenue with value of 700.08 USD Million in 2024.
Segments and Scope
-
Middle East & Africa Self-injections Market to 2032, By Gender
- Male is the largest segment in Middle East & Africa Self-injections Market to 2032 with a revenue of 1.95 USD Billion in the year 2024.
- Male is the Fastest growing segment in Middle East & Africa Self-injections Market to 2032 with a Growth rate of 9.84 % in forecast period 2025-2032.
-
Middle East & Africa Self-injections Market to 2032, By Age Group
- Adult is the largest segment in Middle East & Africa Self-injections Market to 2032 with a revenue of 1.55 USD Billion in the year 2024.
- Adult is the Fastest growing segment in Middle East & Africa Self-injections Market to 2032 with a Growth rate of 10.02 % in forecast period 2025-2032.
-
Middle East & Africa Self-injections Market to 2032, By Application
- Autoimmune Diseases is the largest segment in Middle East & Africa Self-injections Market to 2032 with a revenue of 1.36 USD Billion in the year 2024.
- Autoimmune Diseases is the Fastest growing segment in Middle East & Africa Self-injections Market to 2032 with a Growth rate of 10.39 % in forecast period 2025-2032.
-
Middle East & Africa Self-injections Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Middle East & Africa Self-injections Market to 2032 with a revenue of 1.77 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in Middle East & Africa Self-injections Market to 2032 with a Growth rate of 10.05 % in forecast period 2025-2032.
-
Middle East & Africa Self-injections Market to 2032, By Product Type
- Self-Injection Devices is the largest segment in Middle East & Africa Self-injections Market to 2032 with a revenue of 2.18 USD Billion in the year 2024.
- Self-Injection Formulation is the Fastest growing segment in Middle East & Africa Self-injections Market to 2032 with a Growth rate of 9.55 % in forecast period 2025-2032.
-
Middle East & Africa Self-injections Market to 2032, By Route of Administration
- Subcutaneous is the largest segment in Middle East & Africa Self-injections Market to 2032 with a revenue of 2.68 USD Billion in the year 2024.
- Subcutaneous is the Fastest growing segment in Middle East & Africa Self-injections Market to 2032 with a Growth rate of 9.74 % in forecast period 2025-2032.
-
Middle East & Africa Self-injections Market to 2032, By Dosage Form
- Single Dose is the largest segment in Middle East & Africa Self-injections Market to 2032 with a revenue of 2.08 USD Billion in the year 2024.
- Single Dose is the Fastest growing segment in Middle East & Africa Self-injections Market to 2032 with a Growth rate of 9.89 % in forecast period 2025-2032.
Middle East & Africa Self-injections Market Company Share Analysis
| Company Name |
|
||
| Novo Nordisk A/S | |||
| Sanofi | |||
| AbbVie Inc. | |||
| Amgen Inc. | |||
| Johnson & Johnson Private Limited | |||
Middle East & Africa Self-injections Market Geographical Sales Distribution, 2018-2032 USD Billion
Middle East & Africa Self-injections Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Middle East & Africa Self-injections Market is segmented based on Segmentation Gender,Age Group,Application,Distribution Channel,Product Type,Route of Administration,Dosage Form.
Middle East & Africa Self-injections Market was valued at USD 3.06(Revenue in USD Billion) in 2023.
Middle East & Africa Self-injections Market is projected to grow at a CAGR of 9.70% during the forecast period of 2024 to 2032.
The Subcutaneous segment is expected to dominate the Middle East & Africa Self-injections Market, holding a largest market share of 2.68 USD Billion in 2024
Middle East & Africa Self-injections Market Scope
Middle East & Africa Self-injections Market Segmentation & Scope
Gender
- Female
- Male
Age Group
- Pediatric
- Geriatric
- Adult
Application
- Others
- Hormonal Disorders
- Oncology
- Emergency Drugs
- Pain Management
- Autoimmune Diseases
Distribution Channel
- Others
- Online Pharmacy
- Hospital Pharmacy
- Direct Tender
Product Type
- Self-Injection Formulation
- Self-Injection Devices
Route of Administration
- Others
- Intra muscular
- Subcutaneous
Dosage Form
- Multi-Dose
- Single Dose
Frequently Asked Questions
The Middle East & Africa Self-injections Market is segmented based on Segmentation Gender,Age Group,Application,Distribution Channel,Product Type,Route of Administration,Dosage Form.
Middle East & Africa Self-injections Market was valued at USD 3.06(Revenue in USD Billion) in 2023.
Middle East & Africa Self-injections Market is projected to grow at a CAGR of 9.70% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Self-injections Market for final year is USD 5.86 (USD Billion).
Middle East & Africa Self-injections Market Company Profiling
Frequently Asked Questions
The Middle East & Africa Self-injections Market is segmented based on Segmentation Gender,Age Group,Application,Distribution Channel,Product Type,Route of Administration,Dosage Form.
Middle East & Africa Self-injections Market was valued at USD 3.06(Revenue in USD Billion) in 2023.
Middle East & Africa Self-injections Market is projected to grow at a CAGR of 9.70% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Self-injections Market for final year is USD 5.86 (USD Billion).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.